May 23, 2023 9:05am EDT Lexaria Discovers that DehydraTECH-CBD Treatment in Hypertension Study HYPER-H21-4 Resulted in Reduction in Pro-Inflammatory Biomarkers
May 18, 2023 9:05am EDT Lexaria's Hormone Study Shows Significant Enhancement in Oral Estradiol Delivery
May 11, 2023 9:00am EDT cGMP Manufacturing Complete for Lexaria's Upcoming U.S. Phase 1b Hypertension Clinical Trial
Mar 02, 2023 8:45am EST Lexaria's DehydraTECH-CBD Diabetes Study Demonstrates Weight Loss, Improved Triglyceride and Cholesterol Levels
